Purchase Order 75N95D20P00111
Award Date 7/22/20
Potential Completion Date 11/4/20
Potential Value $20K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Mayagüez, Puerto Rico
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Allergy and Infectious Diseases awarded a purchase order to CDI Laboratories Inc. for $19,412.15 on October 26, 2021, for HuProt v4.0 protein arrays (quantity 16 at $1,058.16 each) to support COVID-19 autoantibody profiling research under the FY26 UDO Initiative. CDI Laboratories is a small disadvantaged business manufacturer. Performance occurs in Mayagüez, Puerto Rico. The order carries firm fixed-price terms and was scheduled for completion by November 26, 2021.
- CDI Laboratories Inc., doing business as CDI Laboratories, has been awarded a $15,000 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide 12 samples of its HUPROT V4.0 Human Proteome Microarray and HUSCAN (PHIP-SEQ) assay service. The contract calls for CDI Laboratories to deliver its proteomics platform and associated sequencing capabilities to support research efforts at the NIH aimed at better understanding...
- <p>The National Institute on Aging awarded a purchase order to CDI Laboratories Inc. for serum profiling of 10 mouse serum samples, with a ceiling value of $17,561.70, on August 12, 2020. CDI Laboratories is a small disadvantaged business. Performance will take place in Mayagüez, Puerto Rico, with an ultimate completion date of September 30, 2020. The order is firm fixed price with no set-aside category.</p>
- <p>The National Cancer Institute awarded a purchase order to CDI Laboratories Inc. for $49,400.00 on July 27, 2026, for NCI PhIP-Seq HuScan service. CDI Laboratories is a small disadvantaged business manufacturer based in Mayagüez, Puerto Rico. Work is performed in Mayagüez, Puerto Rico. The order is firm fixed price with no set-aside category applied. Performance is due by July 26, 2027.</p>
- <p>The National Institute on Aging awarded a purchase order to CDI Laboratories Inc., a small disadvantaged business, for $11,520.00 on July 17, 2018. Work is performed in the United States Minor Outlying Islands. The firm-fixed-price order, with an ultimate completion date of December 17, 2018, procures proteomics and immunological research services, including protein microarray analysis and antibody profiling capabilities that support biomedical research initiatives.</p>
- This firm fixed-price purchase order was awarded by the National Institutes of Health's National Institute on Drug Abuse to CDI Laboratories Inc. of Mayagüez, Puerto Rico for $200,167.30. The contract calls for the delivery of CDI Biolabs HuProt v4.0 and VirD protein arrays within 90 days of the award date. The HuProt v4.0 array contains over 21,000 human proteins from more than 16,000 genes and has a reproducibility rate above 95%. The VirD array profiles 515 conformationally intact human...
- This firm-fixed-price purchase order contract was awarded to CDI Laboratories Inc., a small disadvantaged business, to provide its proprietary HUPROT V4.0 ARRAY protein microarray product and related antibody profiling and analysis services to the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The $121,379.50 contract supports biomedical research efforts, particularly in the areas of infectious diseases, heart/lung disorders, aging, and...
- <p>The National Human Genome Research Institute awarded a purchase order to CDI Laboratories Inc. for $24,000.00 on June 25, 2020, to analyze 40 serum samples using VirScan and HuScan PhIP-Seq package services. CDI Laboratories is a small disadvantaged business. Work is performed in Mayagüez, Puerto Rico. The order was issued under the Coronavirus COVID-19 National Interest Action Code with a firm fixed price and ultimate completion date of June 25, 2020.</p>
- This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to CDI Laboratories Inc., a self-certified small disadvantaged business and manufacturer of goods. The contract, valued at $23,999.72, is for CDI Laboratories to provide its proprietary human proteome microarray assay services to support biomedical research efforts, particularly in the areas of infectious...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging to CDI Laboratories Inc. for immuneprofiler analysis of 30 serum samples using CDI's HuProt microarrays. The purpose is to directly compare the sample data obtained from phage immunoprecipitation sequencing (PhIP-Seq). The contract has a period of performance from April 26, 2021 to April 25, 2022 and a potential value of $218,400.00. The award...